Insider Shareholders with Direct Ownership of Lineage Cell Therapeutics, Inc. (LCTX)
This section provides a comprehensive overview of the insiders with direct ownership of Lineage Cell Therapeutics, Inc. (LCTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Lineage Cell Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Broadwood Partners, L.P.
Director |
14,397,001 | 0 | 34,935,485 $17.5 Million | 11 |
Mar 25, 2022
Added 1.33%
|
|
Alfred D Kingsley
Chairman |
61,800 | 0 | 5,470,245 $2.74 Million | 1 |
Jun 22, 2021
Added 1.12%
|
| 71,720 | 0 | 298,555 $149,277 | 3 |
Nov 22, 2024
Added 11.81%
|
|
|
Brian M Culley
President and CEO |
547,748 | 518,294 | 194,842 $97,421 | 25 |
Nov 21, 2024
Added 17.03%
|
|
Neal C Bradsher
Director |
24,720 | 0 | 87,628 $43,814 | 1 |
Jun 25, 2021
Added 22.0%
|
| 24,720 | 4,720 | 87,500 $43,750 | 2 |
Jun 29, 2021
Reduced 5.12%
|
|
| 35,000 | 0 | 35,000 $17,500 | 1 |
Mar 28, 2022
Added 50.0%
|
|
|
Jill Ann Howe
Chief Financial Officer |
25,500 | 0 | 25,500 $12,750 | 2 |
Nov 26, 2024
Added 37.04%
|
|
George A. Samuel Iii
General Counsel |
27,152 | 4,968 | 22,184 $11,092 | 5 |
Nov 26, 2024
Added 40.34%
|
| 24,720 | 19,142 | 15,578 $7,789 | 2 |
Jun 29, 2021
Reduced 55.13%
|
|
| 10,000 | 0 | 10,000 $5,000 | 1 |
Dec 29, 2023
Added 50.0%
|
|
|
Gary S. Hogge
SVP,Clinical & Medical Affairs |
523,858 | 544,593 | 7,710 $3,855 | 6 |
Feb 11, 2023
Reduced 40.78%
|
|
Alexandra Hernandez
Sr Director Finance/Controller |
6,000 | 6,000 | 0 $0 | 2 |
Mar 30, 2021
Reduced 100.0%
|